Navigation Links
New Superman Glasses for Parkinson's Disease Improve Walking and Quality of Life
Date:9/12/2009

sses on, I walked and turned corners and went through door thresholds as if I had never had Parkinson's.  Now, after my trip, I start and stop some and my walk is not as liquid.  I still think they are a miracle, and I am so glad I have them.  Of course I have put a lot of miles on this old body of mine in the last six weeks."

The GaitAid device is a non-invasive, risk-free aid which brings about a lasting improvement in walking. The portable GaitAid unit clips onto the patient's pants. A computer processor inside the device measures walking movement. The processor feedbacks the walking movement by providing visual and auditory cues through special glasses and earphones. To train with the GaitAid, one takes a walk for 5-30 minutes while wearing the device. The feedback mechanism provides rewarding stimuli to good movement making the training enjoyable. Patients often report high motivation during their training.

Often the improvement is immediate and builds up during the first two to four weeks of daily practice.

To contact Mr. Neil for interview or for more information about the GaitAid, including clinical trials, testimonials, videos and ordering information for a 30 day at home trial period, visit:

www.MediGait.com
Contact Audrey Holmes-Baram
888-777-9906
support(at)medigait.com

# # #

Read the full story at http://www.prweb.com/releases/parkinsons/gaitaid/prweb2857434.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Collaboration yields the right glasses for observing mystery behavior in electrons
2. Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease
3. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
4. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
5. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
6. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
7. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
8. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
9. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
10. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Superman Glasses for Parkinson's Disease Improve Walking and Quality of Life 
(Date:7/28/2015)... -- Faced with increasing challenges such as costly treatments ... the global healthcare industry today is gradually transforming ... or significantly changing the course of a disease, ... medicine as a viable alternative. Regenerative ... with the potential to resolve unmet medical needs ...
(Date:7/27/2015)... 27, 2015 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ... commercializing products for the treatment of cancer, today provides ... it has closed a $1,000,000 unit offering private placement.  ... units of the Company at a price of $0.06 ... share and one common share purchase warrant.  Each whole ...
(Date:7/27/2015)... ... 2015 , ... Brady (NYSE:BRC), a global leader ... Ways to GHS Labels . This video provides useful information on how to ... effectively labeling chemical containers. , “With the fourth and final deadline for HazCom/GHS ...
(Date:7/27/2015)... ... July 27, 2015 , ... BlueInGreen® announced ... The venture will bring the world’s most efficient gas dissolution technology to all ... technologies to both the industrial and municipal markets. With offices located in Sarasota, ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5Quest PharmaTech Closes $1,000,000 Private Placement 2Brady Releases “3 Roads to GHS Labels” Video 2BlueInGreen Brings Water Treatment Technology to Florida 2
... Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ... therapies, today announced that it will hold a ... and year-end financial results and provide a corporate ... Company,s lead product candidate.Jerry McMahon, Ph.D., chairman and ...
... NEW YORK, March 5 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... a letter from the Staff of The Nasdaq Stock ... compliance with Nasdaq Marketplace Rule 4310(c)(3), which requires the ... equity, or $35,000,000 market value of listed securities, or ...
... March 5 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq:, ... company focused on researching,developing, manufacturing and marketing ... the relevant provisions issued by the,Office of ... Finance,National Revenue Department in Liaoning Province and ...
Cached Biology Technology:Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 3Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 4
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... growth of several types of cancer cells lead to ... at Winship Cancer Institute of Emory University have discovered. ... that cancer cells tend to consume more glucose, or ... as the "Warburg effect," honoring discoverer Otto Warburg, a ...
... Like other users of microfluidic systems, National Institute ... faced with an annoying engineering problem: how to simply, ... devices to the external pumps and reservoirs delivering liquids ... randomly picked up two magnets and began playing with ...
... moa, a giant extinct bird, has revealed a new geological ... in the Proceedings of the National Academy of Sciences ... University of Adelaide has reconstructed a history of marine barriers, ... of years, using the first complete genetic history of the ...
Cached Biology News:Cancers' sweet tooth may be weakness 2Novel NIST connector uses magnets for leak-free microfluidic devices 2Extinct moa rewrites New Zealand's history 2
BD BioCoat Laminin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
The F40 piston assembly is supplied as two assemblies to service one F40 pump of a BioLogic DuoFlow workstation....
Mouse monoclonal antibody raised against a full length recombinant ATF3. NCBI Entrez Gene ID = ATF3...
... used as an internal standard for the ... mass spectrometry. 5-OxoETE is a polyunsaturated keto ... in human neutrophils. It stimulates cytosolic calcium ... 2 nM. 5-OxoETE selectively stimulates the migration ...
Biology Products: